AU:GSS Stock Latest News
Company AnnouncementsBCAL backs ex-CEO’s return to Genetic Signatures board, challenges Microba merger terms4d agoGSS
Company AnnouncementsGenetic Signatures Shareholders Back Appointment of New Non-Executive Director5d agoGSS
Company AnnouncementsGenetic Signatures Adjusts Microba Merger Terms and Updates AGM Notice1w agoGSS
Company AnnouncementsGenetic Signatures Softens Merger Terms with Microba, Boosting Its Shareholder Stake1w agoGSS
Company AnnouncementsGenetic Signatures trims costs, preserves cash as it pursues APAC growth and Microba merger3w agoGSS
Company AnnouncementsGenetic Signatures Board Opposes Resolutions Ahead of Extraordinary Meeting1M agoGSSCompany AnnouncementsGenetic Signatures Faces Shareholder-Requested Vote on Director Removal1M agoGSS
Company AnnouncementsGenetic Signatures Sets 2026 AGM Date and Director Nomination Deadline1M agoGSS
Company AnnouncementsGenetic Signatures Announces Departure of Director Caroline Waldron2M agoGSS
Company AnnouncementsMercer Investments Withdraws as Substantial Holder in Genetic Signatures2M agoGSS
Company AnnouncementsGenetic Signatures in Early Merger Talks With Microba to Build Infectious Disease Diagnostics Group2M agoGSS
Company AnnouncementsGenetic Signatures Files ASX Corporate Governance Statement for 20262M agoGSSCompany AnnouncementsGenetic Signatures Tightens Losses and Restructures as Long-Term Deals Underpin Growth Plans2M agoGSS
Company AnnouncementsGenetic Signatures Cuts Costs, Secures Danish Deal and Resets Global Growth Strategy3M agoGSS
Company AnnouncementsGenetic Signatures plays down BCAL stake, stresses business as usual4M agoGSS
Company AnnouncementsBCAL buys 10.2% stake in Genetic Signatures to broaden diagnostics platform4M agoGSS
Company AnnouncementsGenetic Signatures Outlines 90-Day Strategic Review Under Strict Investor Disclaimers4M agoGSS
Company AnnouncementsGenetic Signatures Unveils Post-Review Strategy Ahead of Investor Webinar4M agoGSS

